Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Women With Congenital Adrenal Hyperplasia Have Favorable Pregnancy Outcomes but Prolonged Time to Conceive
Auer, Matthias K. , Minea, Clara E, Beuschlein, Felix , Lottspeich, Christian , Bidlingmaier, Martin , Nowotny, H. , Tschaidse, Lea , Simeoli, Chiara , Reisch, Nicole , Quinkler, Marcus , Bancos, Irina , Beuschlein, Felix , Lottspeich, Christian , Bidlingmaier, Martin , Falhammar, Henrik , Pivonello, Rosario , Reisch, Nicole , Quinkler, Marcus , Bancos, Irina , Meyer, Gesine , Rieger, Eva, Falhammar, Henrik

Journal of the Endocrine Society | December 5, 2024 | Volume: 9 | Issue: 1 | Pages: No page available

10.1210/jendso/bvae211 | PMID 39669654 Get It

Abstract Objective To study pregnancy outcomes and complications in women with congenital adrenal hyperplasia (CAH). Methods A retrospective multicenter study was conducted at tertiary reference centers in 5 countries (Austria, Germany, Italy, Sweden, USA), including 72 adult women with CAH (nonclassic [NC] n = 34, simple virilizing [SV] n = 21, salt wasting [SW] n = 17). Results A total of 133 pregnancies, 112 live births, and 25 abortions were documented. Prolonged latency to pregnancy was observed (median 11 months in SW, 24 months in SV, 8 months in NC), with a notable use of fertility-enhancing medication (25.6%) and assisted reproductive techniques (30.8%). Over half of the women in each group took more than 12 months to conceive. The average number of live births (1.4-1.6 children per woman) was similar across CAH phenotypes and comparable to the general population. Spontaneous abortion rates (18.0%) were also similar across phenotypes. Primary cesarean section rates (60.9%) were higher than in the general population, though 23.8% of women with SV and 29.4% of women with SW gave birth naturally, despite most having undergone genital surgery. Children categorized as small for gestational age were 20.5%. Pregnancy, delivery, and postpartum complications were rare for mothers and neonates. Conclusion The study indicates a prolonged latency to pregnancy and high use of fertility treatments in CAH patients, regardless of phenotype. Abortion rates were not increased, and overall pregnancy and perinatal outcomes were favorable.
Single‐port robotic transanal minimally invasive surgery (SPR‐TAMIS): another giant leap forward?
Ferrari, Davide , Peponis, Thomas , Violante, Tommaso , Ng, Jyi Cheng , Perry, William , Larson, David W. , Behm, Kevin T. , Cheng, Jyi Ng , Perry, William R , Violante, Tommaso , Larson, David W , Ferrari, Davide

Colorectal Disease | December 5, 2024 | Volume: 27 | Issue: 1 | Pages: No page available

10.1111/codi.17252 | PMID 39635954 Get It

AbstractAimMinimally invasive transanal platforms are now the standard of care for select low‐risk rectal tumours. However, existing platforms come with persistent technical challenges. The da Vinci SP Surgical System™ offers a new alternative designed to work effectively in narrow spaces. This technology has the potential to enhance the feasibility and proximal extent of complex transanal resections. This study aimed to describe the morbidity and technical success in patients undergoing single‐port robotic transanal minimally invasive surgery (SPR‐TAMIS). Secondary outcomes include rates of local recurrence.MethodsA retrospective analysis was conducted on all patients who underwent SPR‐TAMIS at our institution between February 2019 and December 2023.ResultsThe study included 31 patients (19 men, 12 women) with a mean age of 61 ± 13.3 years. The average tumour distance from the anal verge was 10 cm. Thirty patients completed SPR‐TAMIS, with one patient requiring conversion to robotic sigmoidectomy due to location in the mid‐sigmoid colon. The mean operating time was 106 ± 42 min. Twenty‐eight out of 30 patients underwent full‐thickness excision and all but two were successfully closed. All specimens were resected intact, and margins were negative in 93.5% of cases. The average tumour size was 13 ± 34 cm2, with 13 lesions classified as adenomas and 16 as adenocarcinomas. All patients who did not undergo associated procedures were discharged on the day of surgery. Two patients experienced 30‐day morbidity. At a mean follow‐up of 18 months (± 13), no local or systemic recurrences were identified.ConclusionSPR‐TAMIS for excision of low‐risk rectal tumours is associated with high rates of technical success and low 30‐day morbidity. Further research is needed to compare SPR‐TAMIS with other techniques to determine potential advantages over current transanal platforms.
Extracorporeal-CPR Versus Conventional-CPR for Adult Patients in Out of Hospital Cardiac Arrest– Systematic Review and Meta-Analysis
Reddy, Swetha , Garcia, Samuel , Hostetter, Logan , Finch, Alexander S. , Bellolio, Fernanda , Gerberi, Dana , Smischney, Nathan J. , Hostetter, Logan J, Smischney, Nathan J , Bellolio, M Fernanda , Guru, Pramod

Journal of Intensive Care Medicine | December 5, 2024 | Volume: 40 | Issue: 2 | Pages: 207-217

10.1177/08850666241303851 | PMID 39635840 Get It

Objective Extracorporeal cardiopulmonary resuscitation (ECPR) utilizes veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in cardiac arrest patients to reduce the risk of mortality and multiorgan dysfunction from systemic hypoperfusion. We aimed to compare clinical outcomes of patients receiving ECPR versus conventional cardiopulmonary resuscitation (CCPR) for refractory cardiac arrest. Data Sources This was a systematic review and meta-analysis. A librarian searched the main databases, Ovid MEDLINE (including epub ahead of print, in-process & other non-indexed citations), Ovid EMBASE and Ovid Cochrane Central Register of Controlled Trials from inception through July 2024. Study Selection We included randomized controlled trials and observational studies that compared the outcomes of ECPR to CCPR in cardiac arrest patients. Primary outcomes were neurological sequelae and survival. Data Extraction We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two reviewers independently screened articles, extracted data on selected articles and performed risk of bias assessments using ROBINS-I for non-randomized controlled trials and the revised Cochrane risk of bias tool for randomized controlled trials with disagreements settled by a third independent reviewer. Data Synthesis Out of 3458 studies identified and screened, 28 studies including 304,360 cardiac arrest patients met eligibility criteria and were included. Survival at hospital discharge was 20% for ECPR versus 3.3% for CCPR (OR 0.48 [CI 0.27, 0.84]). Favorable neurological outcome at hospital discharge was 11.8% for ECPR versus 1.9% for CCPR (OR 0.41 [CI 0.17, 1.01]). Complications from bleeding were ten times higher in the ECPR group (35.3% vs 3.7%; OR 0.08 [0.03, 0.24]). Conclusions ECPR appeared to be superior to CCPR for improved neurological outcome and survival in cardiac arrest patients, although bleeding was increased. There was large heterogeneity in the included studies and outcomes reported. Future prospective studies may improve the identification of subgroups of patients that will benefit most from ECPR. Systematic review and meta-analysis registration: PROSPERO - CRD42023394128.
Rationale and Logistics of Continuous Infusion Cephalosporin Antibiotics
Blunier, Abbie L. , Crocker, R. Jake , May, Stephanie Shealy , Powers, Caroline , Bookstaver, P. Brandon , May, Stephanie S , Bookstaver, P Brandon , Foster, Rachel

Pharmacy | December 5, 2024 | Volume: 12 | Issue: 6 | Pages: 185

10.3390/pharmacy12060185 | PMID 39728850 Get It

Cephalosporins have traditionally been administered as an intermittent infusion. With the knowledge that cephalosporins demonstrate a time-dependent pharmacodynamic profile, administration via continuous infusion may provide more effective antibiotic exposure for successful therapy. Proposed benefits of administration via continuous infusion include less IV manipulation, decreased potential for antibiotic resistance, and potential cost savings. The objective of this review was to provide a detailed assessment of available evidence for the use of continuous infusion cephalosporins and practical dosing and administration recommendations. Studies were gathered and assessed for inclusion via a literature search of PubMed and Ovid MEDLINE using mesh terms [“continuous infusion” and “cephalosporin”], “intermittent infusion”, [“intermittent versus continuous” and “cephalosporin”], “continuous infusion cephalosporin”, as well as specific drug names. References from included studies were also evaluated for inclusion. Data which compared the two administration methods (continuous infusion vs. intermittent infusion) were evaluated. Thirty-five studies were analyzed among several cephalosporins with variable delivery. Dosing regimens utilized in the selected studies were assessed with known compatibility and stability data and further summarized.
How to Implement Clinical 7T MRI—Practical Considerations and Experience with Ultra-High-Field MRI
Cramer, Justin , Ikuta, Ichiro , Ikuta, Ichiro , Zhou, Yuxiang

Bioengineering | December 5, 2024 | Volume: 11 | Issue: 12 | Pages: 1228

10.3390/bioengineering11121228 | PMID 39768046 Get It

The implementation of clinical 7T MRI presents both opportunities and challenges for advanced medical imaging. This tutorial provides practical considerations and experiences with 7T MRI in clinical settings. We first explore the history and evolution of MRI technology, highlighting the benefits of increased signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and susceptibility at 7T. Technical challenges such as increased susceptibility artifacts and RF inhomogeneity are also discussed, along with innovative adaptations. This review also discusses hardware and software considerations, including new parallel transmission head coils and advanced image processing techniques to optimize image quality. Safety considerations, such as managing tissue heating and susceptibility to artifacts, are also discussed. Additionally, clinical applications of 7T MRI are examined, focusing on neurological conditions such as epilepsy, multiple sclerosis, and vascular imaging. Emerging trends in the use of 7T MRI for spectroscopy, perfusion imaging, and multinuclear imaging are explored, with insights into the future of ultra-high-field MRI in clinical practice. This review aims to provide clinicians, technologists, and researchers with a roadmap for successfully implementing 7T MRI in both research and clinical environments.
Recommitting to Housing and Health Care Justice After City of Grants Pass v Johnson
Habib, Anand , Stella, Sarah A. , Farkouh, Elizabeth K. , Grenko, Caleb M., Hart, Dionne , Pasha, Amirala S. , Habib, Anand R , Farkouh, E K , Pasha, Amirala S , Grenko, Caleb M.

American Journal of Public Health | December 4, 2024 | Volume: 115 | Issue: 1 | Pages: 18-22

10.2105/ajph.2024.307870 | PMID 39631088 Get It

Introduction to Generative Artificial Intelligence: Contextualizing the Future
Singh, Rajendra, Kim, Ji Yeon , Glassy, Eric F., Dash, Rajesh , Brodsky, Victor, Seheult, Jansen N. , Baca, Monica E. de , Gu, Qiangqiang , Hoekstra, Shannon, Pritt, Bobbi S. , Seheult, Jansen, Seheult, Jansen N , Pritt, Bobbi S , Singh, Rajendra, Dash, Rajesh C.

Archives of Pathology & Laboratory Medicine | December 4, 2024 | Volume: 149 | Issue: 2 | Pages: 112-122

10.5858/arpa.2024-0221-ra | PMID 39631430 Get It

Context.— Generative artificial intelligence (GAI) is a promising new technology with the potential to transform communication and workflows in health care and pathology. Although new technologies offer advantages, they also come with risks that users, particularly early adopters, must recognize. Given the fast pace of GAI developments, pathologists may find it challenging to stay current with the terminology, technical underpinnings, and latest advancements. Building this knowledge base will enable pathologists to grasp the potential risks and impacts that GAI may have on the future practice of pathology. Objective.— To present key elements of GAI development, evaluation, and implementation in a way that is accessible to pathologists and relevant to laboratory applications. Data Sources.— Information was gathered from recent studies and reviews from PubMed and arXiv. Conclusions.— GAI offers many potential benefits for practicing pathologists. However, the use of GAI in clinical practice requires rigorous oversight and continuous refinement to fully realize its potential and mitigate inherent risks. The performance of GAI is highly dependent on the quality and diversity of the training and fine-tuning data, which can also propagate biases if not carefully managed. Ethical concerns, particularly regarding patient privacy and autonomy, must be addressed to ensure responsible use. By harnessing these emergent technologies, pathologists will be well placed to continue forward as leaders in diagnostic medicine.
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2- mutant clonal hematopoiesis in inflammatory response
Ismail, Wazim Mohammed , Binder, Moritz , Kim, Minsuk , Geyer, Susan M. , Mazzone, Amelia , Finke, Christy M. , Mangaonkar, Abhishek A. , Lee, Jeong‐Heon , Kim, Kwan‐Hyun , Simon, Vernadette, Rohakthar, Fariborz Rakhshan, Munankarmy, Amik , Byeon, Seul Kee , Schwager, Susan M., Harington, Jonathan J., Snyder, Melissa R. , Wieben, Eric D. , Gaspar‐Maia, Alexandre , Patnaik, Mrinal M. , Mohammed Ismail, Wazim , Fernandez, Jenna A., Binder, Moritz , Kim, Minsuk , Mazzone, Amelia , Lee, Jeong-Heon , Wang, Liguo , Kim, Kwan Hyun , Simon, Vernadette A, Rakhshan Rohakthar, Fariborz, Munankarmy, Amik , Byeon, Seul Kee , Harrington, Jonathan J. , Robertson, Keith D , Pandey, Akhilesh , Gaspar-Maia, Alexandre , Patnaik, Mrinal , Fernandez, Jenna , Lasho, Terra L. , Wang, Liguo , Robertson, Keith D. , Pandey, Akhilesh , Chia, Nicholas

Blood Advances | December 4, 2024 | Volume: 9 | Issue: 2 | Pages: 402-416

10.1182/bloodadvances.2024014467 | PMID 39631069 Get It

Abstract DNMT3A and TET2 are epigenetic regulator genes commonly mutated in age-related clonal hematopoiesis (CH). Despite having opposed epigenetic functions, these mutations are associated with increased all-cause mortality and a low risk for progression to hematologic neoplasms. Although individual impacts on the epigenome have been described using different model systems, the phenotypic complexity in humans remains to be elucidated. Here, we make use of a natural inflammatory response occurring during coronavirus disease 2019 (COVID-19), to understand the association of these mutations with inflammatory morbidity (acute respiratory distress syndrome [ARDS]) and mortality. We demonstrate the age-independent, negative impact of DNMT3A mutant (DNMT3Amt) CH on COVID-19–related ARDS and mortality. Using single-cell proteogenomics we show that DNMT3A mutations involve myeloid and lymphoid lineage cells. Using single-cell multiomics sequencing, we identify cell-specific gene expression changes associated with DNMT3A mutations, along with significant epigenomic deregulation affecting enhancer accessibility, resulting in overexpression of interleukin-32 (IL-32), a proinflammatory cytokine that can result in inflammasome activation in monocytes and macrophages. Finally, we show with single-cell resolution that the loss of function of DNMT3A is directly associated with increased chromatin accessibility in mutant cells. Hence, we demonstrate the negative prognostic impact of DNMT3Amt CH on COVID-19–related ARDS and mortality. DNMT3Amt CH in the context of COVID-19, was associated with inflammatory transcriptional priming, resulting in overexpression of IL32. This overexpression was secondary to increased chromatic accessibility, specific to DNMT3Amt CH cells. DNMT3Amt CH can thus serve as a potential biomarker for adverse outcomes in COVID-19.
Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022
Everhart, Alexander , Herrin, Jeph , Karaca‐Mandic, Pinar , Kennel, Kurt A. , Parimi, Nehu, Rosen, Clifford J. , Takagi, Mark, McCoy, Rozalina G. , Rosen, Clifford J. , Everhart, Alexander O , Brito, Juan P , Herrin, Jeph , Karaca-Mandic, Pinar , Kennel, Kurt A , McCoy, Rozalina Grubina , Brito, Juan P. , Clarke, B.L. , Takagi, Mark

The Journal of Clinical Endocrinology & Metabolism | December 4, 2024 | Volume: 110 | Issue: 9 | Pages: 2520-2529

10.1210/clinem/dgae840 | PMID 39811927 Get It

Abstract Context A national assessment of osteoporosis drug therapy (ODT) use can inform the extent of underdiagnosis and undertreatment of osteoporosis. Objective The aim was to describe trends in ODT use by age, sex, fragility fracture, and documented osteoporosis. Methods This was a retrospective analysis of patient-quarter observations for adults aged ≥50 years with commercial or Medicare Advantage health insurance in the OptumLabs Data Warehouse between 2011 and 2022. The primary outcome was the proportion of patient-quarter observations with ODT use stratified by age, sex, fragility fracture, and documented osteoporosis. Cuzick tests were performed to assess trends ODT use. Results Analysis of 166 673 420 patient-quarter observations revealed that over 70% of patients with fragility fractures did not have documented osteoporosis. Among women aged ≥65 years with documented osteoporosis, ODT fill rates increased between 2011 and 2022 from 36.3% to 50.1% for women without fragility fractures (P < .001) and from 30.8% to 43.7% for women with fragility fractures (P < .001). However, ODT fill rates declined (9.2% to 7.4% between 2011 and 2022) for women with fragility fractures and no documented osteoporosis (P = .015). Similar trends were observed among women aged 50-64 years and men. Conclusion ODT use for patients with documented osteoporosis has increased but remains low. Low rates of ODT use for patients with fragility fractures in the absence of documented osteoporosis suggests that underdiagnosis of osteoporosis contributes to underuse of ODTs.
Fibroblast growth factor therapies in biliary tract cancers: current and future state
Siripoon, Teerada , O’Donnell, Conor, Jin, Zhaohui , Mahipal, Amit

Expert Opinion on Investigational Drugs | December 4, 2024 | Volume: 33 | Issue: 12 | Pages: 1245-1255

10.1080/13543784.2024.2430201 | PMID 39629832 Get It